Authors’ response: Relationships between the adverse effects of aspirin and polymorphisms in genes encoding aspirin metabolizing enzymes

por van Oijen, Martijn G H, Laheij, Robert J F, Peters, Wilbert H M
Publicado 2007

The Use of (Network) Meta-Analysis in Clinical Oncology

por ter Veer, Emil, van Oijen, Martijn G. H., van Laarhoven, Hanneke W. M.
Publicado en Front Oncol (2019)

Frequent Use of Antibiotics Is Associated with Colorectal Cancer Risk: Results of a Nested Case–Control Study

por Dik, Vincent K., van Oijen, Martijn G. H., Smeets, Hugo M., Siersema, Peter D.
Publicado en Dig Dis Sci (2015)

Clinical Factors and the Decision to Transfuse Chronic Dialysis Patients

por Whitman, Cynthia B., Shreay, Sanatan, Gitlin, Matthew, van Oijen, Martijn G. H., Spiegel, Brennan M. R.
Publicado 2013

Implementation of real-time probe-based confocal laser endomicroscopy (pCLE) for differentiation of colorectal polyps during routine colonoscopy

por Belderbos, Tim D. G., van Oijen, Martijn G. H., Moons, Leon M. G., Siersema, Peter D.
Publicado en Endosc Int Open (2017)

EXPLAINING PERSISTENT UNDER-USE OF COLONOSCOPIC CANCER SCREENING IN AFRICAN AMERICANS: A SYSTEMATIC REVIEW

por Bromley, Erica G., May, Folasade P., Federer, Lisa, Spiegel, Brennan M.R., van Oijen, Martijn G.H
Publicado en Prev Med (2014)

Constipation-related direct medical costs in 16 887 patients newly diagnosed with chronic constipation

por Dik, Vincent K., Siersema, Peter D., Joseph, Alain, Hodgkins, Paul, Smeets, Hugo M., van Oijen, Martijn G.H.
Publicado 2014

Cutaneous Toxicity After Chemoradiotherapy and PD‐L1 Inhibition in Two Patients with Esophageal Adenocarcinoma: More than Meets the Eye

por van den Ende, Tom, Menting, Stef P., Ambarus, Carmen A., van Oijen, Martijn G.H., van Laarhoven, Hanneke W.M.
Publicado en Oncologist (2019)

Suboptimal prescribing of proton-pump inhibitors in low-dose aspirin users: a cohort study in primary care

por de Jong, Hilda J I, Korevaar, Joke C, van Dijk, Liset, Voogd, Eef, van Dijk, Christel E, van Oijen, Martijn G H
Publicado 2013

A prospective study of bowel preparation for colonoscopy with polyethylene glycol-electrolyte solution versus sodium phosphate in Lynch syndrome: a randomized trial

por van Vugt van Pinxteren, Maria W. J., van Kouwen, Mariëtte C. A., van Oijen, Martijn G. H., van Achterberg, Theo, Nagengast, Fokko M.
Publicado 2012

The efficacy and safety of S-1-based regimens in the first-line treatment of advanced gastric cancer: a systematic review and meta-analysis

por ter Veer, Emil, Mohammad, Nadia Haj, Lodder, Paul, Ngai, Lok Lam, Samaan, Mary, van Oijen, Martijn G. H., van Laarhoven, Hanneke W. M.
Publicado en Gastric Cancer (2016)

The first steps in the evaluation of a "black-box" decision support tool: a protocol and feasibility study for the evaluation of Watson for Oncology

por Keikes, Lotte, Medlock, Stephanie, van de Berg, Daniel J., Zhang, Shuxin, Guicherit, Onno R., Punt, Cornelis J.A., van Oijen, Martijn G.H.
Publicado en J Clin Transl Res (2018)

The Functional −765G→C Polymorphism of the COX-2 Gene May Reduce the Risk of Developing Crohn's Disease

por de Vries, Hilbert S., te Morsche, Rene H. M., van Oijen, Martijn G. H., Nagtegaal, Iris D., Peters, Wilbert H. M., de Jong, Dirk J.
Publicado 2010

Reporting of health-related quality of life in randomized controlled trials involving palliative systemic therapy for esophagogastric cancer: a systematic review

por ter Veer, Emil, van Kleef, Jessy Joy, Sprangers, Mirjam A. G., Haj Mohammad, Nadia, van Oijen, Martijn G. H., van Laarhoven, Hanneke W. M.
Publicado en Gastric Cancer (2018)

Keeping track of all ongoing colorectal cancer trials using a mobile application: Usability and satisfaction results of the Dutch Colorectal Cancer Group Trials application

por Huiskens, Joost, Gałek-Aldridge, Michael S., Bakker, Jean-Michel, Olthof, Pim B., van Gulik, Thomas M., Punt, Cornelis J. A., van Oijen, Martijn G. H.
Publicado en J Clin Transl Res (2018)

Clinicopathological factors influencing outcome in metastatic colorectal cancer patients treated with fluoropyrimidine and bevacizumab maintenance treatment vs observation: an indi...

por Goey, Kaitlyn K H, Elias, Sjoerd G, Hinke, Axel, van Oijen, Martijn G H, Punt, Cornelis J A, Hegewisch-Becker, Susanna, Arnold, Dirk, Koopman, Miriam
Publicado en Br J Cancer (2017)

LOW UPTAKE OF COLORECTAL CANCER SCREENING AMONG AFRICAN AMERICANS IN AN INTEGRATED VETERANS AFFAIRS HEALTH CARE NETWORK

por May, Folasade P., Bromley, Erica G., Reid, Mark W., Baek, Michael, Yoon, Jessica, Cohen, Erica, Lee, Aaron, van Oijen, Martijn G.H., Spiegel, Brennan M.R.
Publicado 2014

Second- and third-line systemic therapy in patients with advanced esophagogastric cancer: a systematic review of the literature

por ter Veer, Emil, Haj Mohammad, Nadia, van Valkenhoef, Gert, Ngai, Lok Lam, Mali, Rosa M. A., van Oijen, Martijn G. H., van Laarhoven, Hanneke W. M.
Publicado en Cancer Metastasis Rev (2016)

Capecitabine, 5-fluorouracil and S-1 based regimens for previously untreated advanced oesophagogastric cancer: A network meta-analysis

por ter Veer, Emil, Ngai, Lok Lam, Valkenhoef, Gert van, Mohammad, Nadia Haj, Anderegg, Maarten C. J., van Oijen, Martijn G. H., van Laarhoven, Hanneke W. M.
Publicado en Sci Rep (2017)

Gastrointestinal Symptoms are Still Prevalent and Negatively Impact Health-Related Quality of Life: A Large Cross-Sectional Population Based Study in The Netherlands

por Tielemans, Merel M., Jaspers Focks, Jeroen, van Rossum, Leo G. M., Eikendal, Ties, Jansen, Jan B. M. J., Laheij, Robert J. F., van Oijen, Martijn G. H.
Publicado 2013